| 1 |
Peru scandal: gaps in oversight of COVID vaccine trial
Khan A
Nature, 592(7856), 685, 2021 |
| 2 |
Path to destruction for a cell-division regulator
Saengboonmee C, Sicinski P
Nature, 592(7856), 690, 2021 |
| 3 |
INDIA'S COVID VACCINE WOES: BY THE NUMBERS
Padma TV
Nature, 592(7855), 500, 2021 |
| 4 |
Tackling the number-one killer in my community
Dance A, Leach D
Nature, 591(7849), 338, 2021 |
| 5 |
COVID-19: use intersectional analyses to close gaps in outcomes and vaccination
Kabanov A, Krasnok A, Seletskiy D
Nature, 591(7849), 202, 2021 |
| 6 |
Signs of self-sustained inflammatory circuits in severe COVID pneumonia
Mould KJ, Janssen WJ
Nature, 590(7847), 553, 2021 |
| 7 |
Mutation alters injury response to drive cancer
Vassiliadis D, Dawson MA
Nature, 590(7847), 2021 |
| 8 |
Variant-proof vaccines - invest now for the next pandemic
Burton DR, Topol EJ
Nature, 590(7846), 386, 2021 |
| 9 |
How the human genome transformed study of rare diseases
Alkuraya FS
Nature, 590(7845), 218, 2021 |
| 10 |
A wealth of discovery built on the Human Genome Project - by the numbers
Gates AJ, Gysi DM, Kellis M, Barabasi AL
Nature, 590(7845), 212, 2021 |
